Skip to main content

Advertisement

Log in

Determination and Distribution Study of Myrislignan in Rat Tissues by RP-HPLC

  • Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

Myrislignan (MRL) existing in nutmeg has been reported to possess inhibition of neoplasm and vascular smooth muscle contraction, and cause a prolonging of hexobarbital-induced hypnosis in mice. In this study, a high-performance liquid chromatography–ultraviolet detection (HPLC–UV) method was developed to analyze MRL in rat tissues. The separation was carried out on an analytical Diamonsil™ ODS C18 HPLC column (250 × 4.6 mm, 5 μm) equipped with a C18 guard column (8 × 4 mm, 5 μm) cartridge system eluted at 1.0 mL min−1 with a mobile phase methanol–H2O (3:1, v/v). Detection wavelength was 270 nm. The concentration of MRL was analyzed in the brain, testes, muscle, adipose, kidney, heart, lung, stomach, intestine, liver, and spleen at various time points between 8 and 128 min following intravenous administration of MRL to rats at a dose of 20.0 mg kg−1. The method was successfully used to study the tissue distribution of MRL. The results contribute to explain the effect of nutmeg on the brain, liver and gastrointestinal tract.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Chinese Pharmacopoeia Commission (2010) Pharmacopoeia of the People’s Republic of China, vol I. China Medical–Pharmaceutical Science & Technology Publishion House, Beijing, pp 126–127

  2. Van GC, Cox PA (1994) Ethnobotany of nutmeg in the spice islands. J Ethnopharmacol 42:117–124

    Article  Google Scholar 

  3. Barceloux DG (2009) Nutmeg (Myristica fragrans Houtt.). Dis Mon 55:373–379

    Article  Google Scholar 

  4. Ram A, Lauria P, Gupta R, Sharma VN (1996) Hypolipidaemic effect of Myristica fragrans fruit extract in rabbits. J Ethnopharmacol 55:49–53

    Article  CAS  Google Scholar 

  5. Sharma A, Sharma M, Joshi S (2009) Lipid lowering effects of Myristica fragrans seeds (crude and isolated fraction) in experimental hyperlipidemic rabbits. Atheroscler Suppl 10:e808

    Article  Google Scholar 

  6. Sonavane GS, Sarveiya VP, Kasture VS, Kasture SB (2002) Anxiogenic activity of Myristica fragrans seeds. Pharmacol Biochem Behav 71:239–244

    Article  CAS  Google Scholar 

  7. Chung JY, Choo JH, Lee MH, Hwang JK (2006) Anticariogenic activity of macelignan isolated from Myristica fragrans (nutmeg) against Streptococcus mutans. Phytomedicine 13:261–266

    Article  CAS  Google Scholar 

  8. Kwon HS, Kim MJ, Jeong HJ, Yang MS, Park KH, Jeong TS, Lee WS (2008) Low-density lipoprotein (LDL)-antioxidant lignans from Myristica fragrans seeds. Bioorg Med Chem Lett 18:194–198

    Article  CAS  Google Scholar 

  9. Barceloux DG (2008) Medical toxicology of natural substances: foods, fungi, medicinal herbs, toxic plants, and venomous animals, 1st edn. John Wiley & Sons, Hoboken, pp 67–70

    Google Scholar 

  10. Yang XW, Aihemaiti MMT, Li Q, Xu W, Yang Z, Xiao SY (2003) Studies on chemical constituents from seeds of Myristica fragrans. Chin Tradit Herb Drugs 34(suppl):93–96

    Google Scholar 

  11. Yang XW, Huang X, Aihemaiti MMT (2008) New neolignan from seed of Myristica fragrans. China J Chin Mater Med 33:397–402

    CAS  Google Scholar 

  12. Huang X, Yang XW (2007) GC–MS analysis of essential oil from nutmeg processed by different traditional methods. China J Chin Mater Med 32:1669–1675

    CAS  Google Scholar 

  13. Wang Y, Yang XW (2007) GC–MS analysis of essential oil from the seeds of Myristica fragrans Houtt in Indonesia. China J Tradit Chin Med Pharm 22:603–606

    Google Scholar 

  14. Wang Y, Yang XW (2008) Quantitative determination of neolignanoids in the seeds of Myristica fragrans. Modern Chin Med 10:10–13

    CAS  Google Scholar 

  15. Hattori M, Hada S, Watahiki A, Ihara H, Shu YZ, Kakiuchi N, Mizuno T, Namba T (1986) Studies on dental caries prevention by traditional medicines. X. Antibacterial action of phenolic components from mace against Streptococcus mutans. Chem Pharm Bull 34:3885–3893

    Article  CAS  Google Scholar 

  16. Matsumoto A, Matsumoto T, Tokuda H (1991) Lignans from mace as neoplasm inhibitors. Japan Kokai Tokkyo Koho, p. 4

  17. Nakajima K, Yamazaki T, Kawashima K, Shinho Y, Kurashige T, Nohara T, Kinjo Y, Imakiire M, Nishimura M (1999) Vascular smooth muscle contraction inhibitors from Myristica. Japan Kokai Tokkyo Koho, p 8

  18. Shin KH, Woo WS (1990) Inhibition and induction of hepatic mixed function oxidase by phenylpropanoids from the seeds of Myristica fragrans. Kor Biochem J 23:122–127

    CAS  Google Scholar 

  19. Miyazawa M, Kasahara H, Kameoka H (1996) Antifungal activities of 8-O-4’-neolignans from Myristica fragrans. Nat Prod Lett 8:271–273

    Article  CAS  Google Scholar 

  20. Yang XW, Huang X, Ma L, Wu Q, Xu W (2010) The intestinal permeability of neolignans from the seeds of Myristica fragrans in the Caco-2 cell monolayer model. Planta Med 76:1587–1591

    Article  CAS  Google Scholar 

  21. Li F, Yang XW (2008) Biotransformation of myrislignan by rat liver microsomes in vitro. Phytochemistry 69:765–771

    Article  CAS  Google Scholar 

  22. Li F, Yang XW (2008) Quantification of myrislignan in rat plasma by solid-phase extraction and reversed-phase high-performance liquid chromatography. Biomed Chromatogr 22:601–605

    Article  CAS  Google Scholar 

  23. Yan HHN, Cheng CY (2005) Blood–testis barrier dynamics are regulated by an engagement/disengagement mechanism between tight and adherens junctions via peripheral adaptors. Proc Nat Acad Sci USA 102:11722–11727

    Article  CAS  Google Scholar 

  24. Dhingra D, Sharma A (2006) Antidepressant-like activity of n-hexane extract of nutmeg (Myristica fragrans) seeds in mice. J Med Food 9:84–89

    Article  Google Scholar 

  25. Tajuddin AS, Latif A, Qasmi IA, Amin KMY (2005) An experimental study of sexual function improving effect of Myristica fragrans Houtt. (nutmeg). BMC Complement Alternative Med 5:16

    Article  CAS  Google Scholar 

  26. Li F, Yang XW, Cheng Y, Gao W (2008) In vitro metabolism of myrislignan in the seeds of Myristica fragrans. Chin J New Drugs 17:560–564

    CAS  Google Scholar 

  27. Hattori M, Yang XW, Miyashiro H, Namba T (1993) Inhibitory effects of monomeric and dimeric phenylpropanoids from mace on lipid peroxidation in vivo and in vitro. Phytother Res 7:395–401

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank the NIH Fellows Editorial Board (NIH, Bethesda) for editorial assistance. This research was supported partly by the National Natural Science Foundation of China (30973863; 81161120429), National Key Technology Research and Development Program of China (2011BAI07B08), and Beijing Municipal Special–Purpose Science Foundation of China (Z0004105040311).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiu-Wei Yang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 38 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Liu, JX., Zhang, YB. et al. Determination and Distribution Study of Myrislignan in Rat Tissues by RP-HPLC. Chromatographia 75, 541–549 (2012). https://doi.org/10.1007/s10337-012-2219-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-012-2219-3

Keywords

Navigation